2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO HCC Update: Is Tremelimumab + Durvalumab Effective, Tolerable, and Biologically Active in Advanced Disease?

112 views
July 14, 2020
Comments 0
Login to view comments. Click here to Login